Camrelizumab Combined With Apatinib Mesylate Tablets, Nab-paclitaxel & S-1

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05028933` - IMC001 for Clinical Research on Advanced Digestive System Malignancies	Phase 1
Completed	`NCT00821990` - Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer	Phase 3
Recruiting	`NCT04385641` - Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer	N/A
Completed	`NCT01248403` - A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy	Phase 3
Not yet recruiting	`NCT01206218` - Evaluation of Customized Treatment According to BRCA1 Assessment in Patients With Advanced Gastric Cancer	Phase 2/Phase 3
Completed	`NCT00976768` - Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin	Phase 2
Completed	`NCT01851941` - A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer	Phase 2
Active, not recruiting	`NCT03223376` - A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)	Phase 3
Completed	`NCT03609359` - Lenvatinib and Pembrolizumab Simultaneous Combination Study	Phase 2
Completed	`NCT03350477` - Bioinformation Therapy for Gastric Cancer	Phase 2/Phase 3
Completed	`NCT02935634` - A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer	Phase 2
Active, not recruiting	`NCT03579784` - Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer	Phase 2
Completed	`NCT02952729` - Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2	Phase 1
Recruiting	`NCT02072317` - Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer	Phase 2
Completed	`NCT01472250` - A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China	N/A
Completed	`NCT01503372` - FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer	Phase 2
Terminated	`NCT01402401` - Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients	Phase 2
Recruiting	`NCT01015339` - Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction	Phase 3
Completed	`NCT01238055` - Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer	Phase 2
Completed	`NCT01441336` - Laparoscopic Gastrectomy for Advanced Gastric Cancer	Phase 2

NCT number	NCT04195828
Study type	Interventional
Source	Fujian Medical University
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	June 18, 2020
Completion date	March 31, 2025

Camrelizumab Combined With Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms